Sign In
Buy AXSM
$212.85
+0.680 (+0.320%)
At Close: Aug 05, 2026
Why Is Axsome Therapeutics (AXSM) Stock Up Today?
11:46am, Thursday, 13'th Oct 2022
Source: ra2 studio/Shutterstock Today may be less than stellar for Relmada Therapeutics (NASDAQ: RLMD ), but it's certainly a great day for Axsome Therapeutics (NASDAQ: AXSM ). Apparently, Relmada's d
Delta Air Lines, Walgreens Boots Alliance And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
11:24am, Thursday, 13'th Oct 2022 Benzinga
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Meta Materials Inc. (NASDAQ: MMAT) shares climbed 13.3% to $1.19 in pr
3 Red-Hot Stocks That Could Continue to Beat the Market
10:30am, Thursday, 13'th Oct 2022 The Motley Fool
Investors are betting on these companies' revenue growth prospects.
Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges
09:25am, Thursday, 13'th Oct 2022
Relmada stock crashed Thursday after its depression treatment failed a final-phase test, helping bolster rival Axsome. AXSM stock surged.
3 Red-Hot Stocks That Could Continue to Beat the Market
06:30am, Thursday, 13'th Oct 2022
Investors are betting on these companies' revenue growth prospects.
Acadia (ACAD) Thrives on Nuplazid, Overdependence a Concern
02:57pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
Acadia's (ACAD) lead drug, Nuplazid, is approved for treating hallucinations and delusions associated with Parkinson's disease psychosis. Sole dependence on Nuplazid for growth remains an overhang.
Got $1,000? These 3 Stocks Could Double Your Money in 5 Years.
02:00pm, Wednesday, 12'th Oct 2022 The Motley Fool
All three stocks are worth keeping a lot longer than half a decade.
Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold
10:00am, Wednesday, 12'th Oct 2022 The Motley Fool
Vertex already generates billions in revenue -- but there may be more to come.
Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold
06:00am, Wednesday, 12'th Oct 2022
Vertex already generates billions in revenue -- but there may be more to come.
Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022
11:00am, Monday, 10'th Oct 2022 GlobeNewswire Inc.
NEW YORK, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous syst
Better Buy: Moderna vs. Axsome Therapeutics
10:00am, Monday, 10'th Oct 2022 The Motley Fool
Both of these biotechs offer exciting future prospects.
These 7 Biotech Stocks Are Set to Boom in 2023
06:15am, Monday, 10'th Oct 2022
Among biotech stocks, there are several established names that have products in markets and deep pipelines. These companies deliver predictable revenue and earnings, and maybe even a dividend for good
Better Buy: Moderna vs. Axsome Therapeutics
06:00am, Monday, 10'th Oct 2022
Both of these biotechs offer exciting future prospects.
If You Invested $5,000 in Axsome Therapeutics in 2019, This Is How Much You Would Have Today
10:30am, Saturday, 08'th Oct 2022 The Motley Fool
Could the stock keep performing?
Acadia (ACAD) Rises More Than 14% in 3 Months: Here's Why
05:36pm, Thursday, 06'th Oct 2022 Zacks Investment Research
Acadia's (ACAD) Nuplazid, approved for treating hallucinations and delusions associated with Parkinson's disease psychosis, is driving revenues. Other candidates are also making good progress.
